Makana Therapeutics
PrivateLast Round
Grant
Jun 12, 2023
Total Funding Raised
$2.25M
Company Overview
Makana Therapeutics is a biotechnology company that develops genetically modified pigs for xenotransplantation to address the organ donor shortage.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Makana Therapeutics Comparables
Compare Makana Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| eGenesis | 84% | |
| NZeno | 84% | |
| PorMedTec Co., Ltd. | 81% | |
Makana Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 12, 2023 | ||||
| Grant | Nov 16, 2021 |
Makana Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kidney Innovation Accelerator | Grant |
Makana Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Makana Therapeutics's valuation, stock price, and market status.